- Home
- SBET vs IMTX Comparison
SBET vs IMTX Comparison
Compare SBET & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- IMTX
- Stock Information
- Founded
- SBET 1995
- IMTX N/A
- Country
- SBET United States
- IMTX Germany
- Employees
- SBET N/A
- IMTX N/A
- Industry
- SBET Computer Software: Prepackaged Software
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBET Technology
- IMTX Health Care
- Exchange
- SBET Nasdaq
- IMTX Nasdaq
- Market Cap
- SBET 618.0M
- IMTX 653.9M
- IPO Year
- SBET 1997
- IMTX N/A
- Fundamental
- Price
- SBET $20.87
- IMTX $5.69
- Analyst Decision
- SBET
- IMTX Strong Buy
- Analyst Count
- SBET 0
- IMTX 4
- Target Price
- SBET N/A
- IMTX $14.67
- AVG Volume (30 Days)
- SBET 49.9M
- IMTX 572.9K
- Earning Date
- SBET 08-14-2025
- IMTX 08-13-2025
- Dividend Yield
- SBET N/A
- IMTX N/A
- EPS Growth
- SBET N/A
- IMTX N/A
- EPS
- SBET N/A
- IMTX N/A
- Revenue
- SBET $3,144,153.00
- IMTX $152,823,253.00
- Revenue This Year
- SBET N/A
- IMTX N/A
- Revenue Next Year
- SBET N/A
- IMTX $1.92
- P/E Ratio
- SBET N/A
- IMTX N/A
- Revenue Growth
- SBET N/A
- IMTX 83.61
- 52 Week Low
- SBET $2.26
- IMTX $3.30
- 52 Week High
- SBET $124.12
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- SBET 49.62
- IMTX 41.21
- Support Level
- SBET $17.91
- IMTX $5.42
- Resistance Level
- SBET $24.55
- IMTX $6.47
- Average True Range (ATR)
- SBET 2.67
- IMTX 0.36
- MACD
- SBET -0.33
- IMTX -0.11
- Stochastic Oscillator
- SBET 28.60
- IMTX 21.77
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.